Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Vomiting × Laser Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 2 Skin Neoplasms 2 Laryngeal Neoplasms 2 Dyspareunia 2 Carcinoma, Hepatocellular 2 Carcinoma, Basal Cell 2 Breast Neoplasms 2 Warts 1 Vulvar Neoplasms 1 Vomiting 1 Vaginal Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomatitis 1 Squamous Intraepithelial Lesions 1 Squamous Cell Carcinoma of Head and Neck 1 Radiodermatitis 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Papilloma 1 Pain 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Laryngeal papillomatosis 1 Keratosis, Actinic 1

Interventions

Dexamethasone 35 Aprepitant 30 Palonosetron 24 Ondansetron 21 Granisetron 14 fosaprepitant 13 Calcium Dobesilate 12 Olanzapine 11 Therapeutics 7 ramosetron 6 dexamethasone acetate 5 Tropisetron 5 Doxorubicin 5 Cyclophosphamide 5 Metoclopramide 4 netupitant, palosentron drug combination 3 netupitant 3 dolasetron 3 dexamethasone 21-phosphate 3 Vincristine 3 Surveys and Questionnaires 3 Prochlorperazine 3 Lorazepam 3 Dronabinol 3 Diphenhydramine 3 Acupressure 3 ginger extract 2 Thalidomide 2 Sugars 2 Radiotherapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03354741 2023-11-15

NAUVOLA

Centre Hospitalier Universitaire de Nice

Phase NA Completed

Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡